KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

VIKING GLOBAL INVESTORS LP's Holding History (CIK: 0001103804)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 1,820,462 Value ($000) $4,842 Avg Close — Range —
Q4 2023
Shares 1,820,462 Value ($000) $4,314 Avg Close — Range —
Q3 2023
Shares 1,820,462 Value ($000) $2,549 Avg Close — Range —
Q2 2023
Shares 1,820,462 Value ($000) $5,516 Avg Close — Range —
Q1 2023
Shares 1,820,462 Value ($000) $11,378 Avg Close — Range —
Q4 2022
Shares 1,820,462 Value ($000) $11,105 Avg Close — Range —
Q3 2022
Shares 1,820,462 Value ($000) $21,755 Avg Close — Range —
Q2 2022
Shares 1,820,462 Value ($000) $22,956 Avg Close — Range —
Q1 2022
Shares 1,820,462 Value ($000) $20,498 Avg Close — Range —
Q4 2021
Shares 1,820,462 Value ($000) $32,259 Avg Close — Range —
Q3 2021
Shares 1,820,462 Value ($000) $41,907 Avg Close — Range —
Q2 2021
Shares 1,820,462 Value ($000) $42,380 Avg Close — Range —
Q1 2021
Shares 1,872,023 Value ($000) $58,332 Avg Close — Range —
Q4 2020
Shares 1,872,023 Value ($000) $74,469 Avg Close — Range —